Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
15.0%
% of IHE's 41 holdings also in MEDX
20.0%
% of MEDX's 30 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 24.2% | 17.0% | 17.0% |
|
JOHNSON & JOHNSON | 25.1% | 4.9% | 4.9% |
|
BRISTOL-MYERS SQUIBB CO | 4.8% | 6.3% | 4.8% |
|
PFIZER INC | 4.7% | 4.0% | 4.0% |
|
MERCK & CO. INC. | 4.2% | 3.7% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to MEDX
|
JOHNSON & JOHNSON | 20.2% |
|
ELI LILLY & CO | 7.2% |
|
INTRA-CELLULAR THERAPIES INC | 4.5% |
|
ROYALTY PHARMA PLC CLASS A | 4.4% |
|
ZOETIS INC | 4.3% |
|
VIATRIS, INC. | 3.1% |
 |
JAZZ PHARMACEUTICALS PLC | 2.9% |
|
ELANCO ANIMAL HEALTH, INC. | 1.9% |
|
CORCEPT THERAPEUTICS INC | 1.8% |
|
AXSOME THERAPEUTICS, INC. | 1.7% |
IHE Underweight Relative to MEDX
|
ABBVIE INC | -9.6% |
 |
NOVARTIS AG-ADR | -6.4% |
|
AMGEN INC | -6.3% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ALKERMES PLC | -4.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.1% |
|
REGENERON PHARMACEUTICALS | -3.0% |
|
CRISPR THERAPEUTICS AG | -2.8% |
|
BIOGEN IDEC INC | -2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.6% |